Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Feb 2026 for Sangamo Therapeutics, INC, €661.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Scott B. Willoughby: trading record in brief
This profile gathers the share dealings of Scott B. Willoughby in Sangamo Therapeutics, Inc, where the filings describe the role as senior executive. The record holds 37 filings, for trades running from 13 August 2021 to 25 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 26 February 2026 came the latest disclosure, a share grant for €4,931 in Sangamo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott B. Willoughby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
1,650 shares@ US$0.47250.2% of flowCommon StockSEC:0001877368-26-000004:0
36,676 shares@ US$0.39854.6% of flowCommon StockSEC:0001877368-26-000002:0
2,035 shares@ US$0.41660.3% of flowCommon StockSEC:0001877368-25-000007:0
44,122 shares@ US$0.669.8% of flowCommon StockSEC:0001877368-25-000005:0
1,434 shares@ US$0.58630.3% of flowCommon StockSEC:0001415889-25-023077:0
31,866 shares@ US$0.47985.6% of flowCommon StockSEC:0001415889-25-020244:0
1,433 shares@ US$0.47330.2% of flowCommon StockSEC:0001415889-25-014695:0
31,866 shares@ US$0.77639.9% of flowCommon StockSEC:0001415889-25-011287:0
1,434 shares@ US$1.000.6% of flowCommon StockSEC:0001415889-25-005706:0
129,549 shares@ US$1.1565.3% of flowCommon StockSEC:0001415889-25-002021:0
1,430 shares@ US$1.881.2% of flowCommon StockSEC:0001415889-24-027705:0
1,430 shares@ US$0.860.5% of flowCommon StockSEC:0001415889-24-022312:0
892 shares@ US$0.97510.4% of flowCommon StockSEC:0001415889-24-021365:0
1,400 shares@ US$0.600.4% of flowCommon StockSEC:0001415889-24-014796:0
4,379 shares@ US$1.132.1% of flowCommon StockSEC:0001415889-24-005550:0
712,500 shares0Common StockSEC:0001415889-24-001757:0
1,329 shares@ US$0.38210.2% of flowCommon StockSEC:0001209191-23-056791:0
1,329 shares@ US$0.770.4% of flowCommon StockSEC:0001209191-23-047577:0
864 shares@ US$1.080.4% of flowCommon StockSEC:0001209191-23-045879:0
1,328 shares@ US$1.330.8% of flowCommon StockSEC:0001209191-23-032914:0
3,977 shares@ US$1.652.7% of flowCommon StockSEC:0001209191-23-025721:0
42,750 shares0Common StockSEC:0001209191-23-016399:0
864 shares@ US$6.332.4% of flowCommon StockSEC:0001209191-22-046022:0
140 shares@ US$4.150.2% of flowCommon StockSEC:0001209191-22-026801:0
3,976 shares@ US$4.706.4% of flowCommon StockSEC:0001209191-22-025671:0
25 of 28 declarations
